Vimarsana
Biggest News Aggregation in the World

Page 19 - Science User Facility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Science User Facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Science User Facility Today - Breaking & Trending Today

DOE's HPC4EI Program Award Helps Argonne Steer Manufacturers Toward Supercomputing - Vimarsana News

DOE's HPC4EI Program Award Helps Argonne Steer Manufacturers Toward Supercomputing

Oct. 19, 2021 -- Engineers and scientists at the U.S. Department of Energy’s (DOE) Argonne National Laboratory were awarded nearly $1.2 million in funding

ALCF Summer Students Gain Hands-On Experience with AI and Supercomputing - Vimarsana News

ALCF Summer Students Gain Hands-On Experience with AI and Supercomputing

Oct. 6, 2021 -- As part of the ALCF’s annual internship program, 33 college students were paired with mentors to work on real-world scientific computing

Probing the Powers of Zeolite - Vimarsana News

Probing the Powers of Zeolite

University of Delaware’s Mark LaFollette is studying these catalysts at Brookhaven through DOE’s Office of Science Graduate Student Research Program.

Source: bnl.gov
Through the Thin-film Glass, Researchers Spot a New Liquid Phase - Vimarsana News

Through the Thin-film Glass, Researchers Spot a New Liquid Phase

A new study on thin films of glass shows how they can be fabricated to be denser and more stable, providing a framework for new applications and devices through better design.

Source: bnl.gov
Existing drug may be effective in treating SARS-CoV-2 - Vimarsana News

Existing drug may be effective in treating SARS-CoV-2

Existing drug may be effective in treating SARS-CoV-2 Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads. X-ray crystallography gave us a strong indication of how this drug works, and we became confident that it has a chance to work in humans." Nir Drayman...